Company Profile

Daxor Corporation (AKA: Daxor Pharmaceutical)
Profile last edited on: 12/2/2023      CAGE: 7ETX9      UEI: QGB8LQAGTAH8

Business Identifier: Medical instrumentation and biotechnology, focused on blood volume analysis
Year Founded
1971
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

109 Meco Lane
Oak Ridge, TN 37830
   (865) 425-0551
   info@daxor.com
   www.daxor.com
Location: Single
Congr. District: 03
County: Anderson

Public Profile

Daxor Corporation (now NASDAQ:DXR) is a medical instrumentation firm in the biotechnology arena focused on blood volume measurement. The firm develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. As the pioneer in blood volume analysis, Daxor management provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from a User's BVA system throughout their facility. With a long-standing commitment to improving care and numerous studies validating thefirm's technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis wit the firm's vision being optimal blood volume for all.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Publicly Traded
Stock Info
NASDAQ : DXR
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Michael R Feldschuh -- President and Chief Executive

  Randy Dodgen -- Operations Manager

  Jonathan Feldschuh -- Chief Scientific Officer

  Kathryn A Kornafel -- Vice President Marketing & Commercial Development

  Guido Manzo -- VP of Sales

  Robert J Michel -- Chief Financial Officer

  Bret Shapiro -- Investor Relations

  Soren Thompson -- Vice President Business Development